Alopecia areata: topical immunotherapy treatment with diphencyprone

被引:28
作者
Avgerinou, G. [1 ]
Gregoriou, S. [1 ]
Rigopoulos, D. [1 ]
Stratigos, A. [1 ]
Kalogeromitros, D. [1 ]
Katsambas, A. [1 ]
机构
[1] Univ Athens, Sch Med, A Sygros Hosp, Acad Dept Dermatol 1, GR-11527 Athens, Greece
关键词
alopecia areata; diphencyprone; treatment;
D O I
10.1111/j.1468-3083.2007.02411.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Topical immunotherapy with diphencyprone (DPCP) is considered the most effective treatment of alopecia areata (AA). Objective To assess the efficacy of DPCP in the treatment of extensive or long-lasting AA in Greek patients. Methods Sixty-four patients with extensive and/or long-lasting AA were sensitized with 2% diphencyprone. During each weekly subsequent visit, patients were treated with gradually denser concentrations adjusted in order to maintain erythema and itch on the patient's scalp for 48 h. Patients' hair re-growth was evaluated every 3 months for 2 years. Results Forty-five patients responded among the 54 completing therapy (83.3%). Initial response was observed 3.48 +/- 1.05 months after the initial treatment. Twenty patients among the responders achieved a grade 4 response, 15 patients achieved grade 3, 9 patients achieved grade 2, and 1 patient achieved a grade 1 response. The mean duration of treatment until maximum response was 6.14 +/- 1.48 months. Thirty-one patients (68.9%) had a relapse during follow-up and were treated again. The only adverse event among patients completing therapy was contact dermatitis of the face or neck (9 of 54) that resolved after topical corticosteroid application within 7 days. Statistical analysis did not establish any association among duration of AA, age, gender, atopic diathesis, nail involvement and presence of thyroid antibodies with response to treatment. Conclusion Treatment of Greek patients with AA with diphencyprone presents high response rates similar to those reported by previous studies. The treatment is adequately tolerated by most of the patients, and they are willing to repeat it in cases of relapse.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 21 条
[1]   Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata [J].
Agarwal, A. ;
Nath, J. ;
Barua, K. N. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (10) :1375-1376
[2]  
AVGERINOU G, 1989, DERMATOLOGY EUROPE, P723
[3]  
AVGERINOU G, 1993, 3 C EADV COP DENM
[4]   The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata [J].
Cotellessa, C ;
Peris, K ;
Caracciolo, E ;
Mordenti, C ;
Chimenti, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) :73-76
[5]   Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata [J].
Firooz, A ;
Bouzari, N ;
Mojtahed, F ;
Pazoki-Toroudi, H ;
Nassiri-Kashani, M ;
Davoudi, M ;
Dowlati, Y .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (03) :393-394
[6]  
GALADARI I, ALLERG IMMUNOL PARIS, V35, P397
[7]   Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history [J].
Goh, C. ;
Finkel, M. ;
Christos, P. J. ;
Sinha, A. A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (09) :1055-1060
[8]   Diphencyprone for the treatment of alopecia areata - More data and new aspects [J].
Happle, R .
ARCHIVES OF DERMATOLOGY, 2002, 138 (01) :112-113
[9]   DIPHENCYPRONE IN THE TREATMENT OF LONG-STANDING ALOPECIA-AREATA [J].
HULL, SM ;
NORRIS, JF .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (03) :367-374
[10]   ALOPECIA-AREATA IN CHILDREN - RESPONSE TO TREATMENT WITH DIPHENCYPRONE [J].
HULL, SM ;
PEPALL, L ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1991, 125 (02) :164-168